Ezt az oldalt automatikusan lefordították, és a fordítás pontossága nem garantált. Kérjük, olvassa el a angol verzió forrásszöveghez.

Management of Focal Cartilage Lesions of the Knee: The Benefits of an Autograft Procedure (CART-MCI Knee)

2026. június 9. frissítette: Louis Pasteur Santé Lorraine

Cartilage is a tissue whose primary function is to transmit and distribute loads when joints are under stress. It acts as a buffer between bones at the joints. Over time, or due to diseases and/or trauma, this surface can disappear, leading to pain and limited movement. Cartilage lesions are particularly difficult to treat because cartilage has a limited capacity for regeneration.

When cartilage lesions are characterized by a localized defect, several surgical techniques are available to restore cartilage tissue to the affected area.

The most frequently used surgical technique is bone marrow stimulation, also known as microfracture. The cartilage lesion is debrided, the subchondral bone exposed, and then a punch is used to perforate the subchondral bone, allowing a clot to form within the defect. This clot will proliferate and differentiate into scar tissue. However, this cellular differentiation results in fibrocartilaginous tissue rather than hyaline cartilage, sometimes with disappointing clinical outcomes.

Other techniques for cartilage restoration exist and are used routinely, including more biological techniques such as Minced Cartilage Implantation (MCI). Autologous cartilage is first harvested from around the defect, chopped into very small fragments, and then reimplanted. Cartilage fragmentation activates cell proliferation and migration, followed by the synthesis of an extracellular, cartilaginous matrix. The effectiveness of this fragmentation is increased with fine fragments (<0.3 mm). Cell proliferation and activity appear to be stimulated by the systematic addition of PRP (Platelet-Rich Plasma) during the MCI procedure.

The expected benefit of an MCI approach lies in clinical improvement and better cartilage regeneration (observed on imaging) compared to microfracture.

The objective is to conduct a controlled, randomized, blinded study (blinded to both the patient and the MRI assessor of the bone graft) to determine the benefit of an MCI approach versus microfracture.

A tanulmány áttekintése

Részletes leírás

Objective : Primary objective: To demonstrate the benefit of the MCI approach in terms of lesion filling at 24 months post-surgery.

Secondary objectives:

  • To demonstrate the clinical benefit (based on functional scores and the need for re-intervention) of the MCI approach at different follow-up visits.
  • To describe all post-operative complications.
  • To demonstrate the benefit of the MCI approach in terms of lesion filling at 24 months post-surgery in patients with lesions larger than 2 cm².

Outcome Measures :

Primary endpoint: Bone grafting will be measured by magnetic resonance imaging at 24 months using the MOCART score (Magnetic Resonance Observation of Cartilage Repair Tissue 2.0 Knee Score), which assesses the rate and quality of grafting. The evaluator will be blinded to the randomization arm.

Secondary endpoints:

  • Functional scores at baseline, at 3, 9, and 24 months:
  • Visual Analog Scale (VAS)
  • Self Knee Value (SKV)
  • Knee Injury and Osteoarthritis Outcome Score (KOOS score)
  • and Tegner-Lysholm activity score
  • Postoperative complications from all causes at each visit
  • Need for reoperation at 3, 9, and 24 months post-surgery.

Single-center, controlled, randomized, blinded (patient and MRI assessor blinded), two parallel arms with a 1:1 ratio:

  • Arm 1: Microfractures
  • Arm 2: Minced Cartilage Implantation (MCI)

Randomization will be stratified by:

  • Age (< 30 years vs ≥ 30 years)
  • Lesion size (< 2 cm² vs ≥ 2 cm²)

Inclusion criteria:

  • Male or female, aged over 18 years.
  • Patient who has signed an informed consent form.
  • Patient with focal cartilage lesions of the knee, classified as grade 4 on MRI according to the International Cartilage Repair Society classification (exposure of subchondral bone), regardless of their size, and for which surgery is indicated.
  • Be affiliated with a social security scheme or a beneficiary of such a scheme

Exclusion criteria:

  • Revision knee surgery
  • Body Mass Index (BMI) > 27 kg/m2
  • Joint space narrowing on standard radiographic examination
  • Refusal of consent
  • Patient unable to read, write, or understand French
  • Vulnerable patient according to Article L1121-6 of the French Public Health Code (CSP)
  • Adult patient under guardianship, curatorship, or legal protection
  • Patient unable to personally give consent according to Article L.1121-8 of the French Public Health Code (CSP) or an adult protected by law
  • Pregnant or breastfeeding woman according to Article L1121-5 of the French Public Health Code (CSP)
  • Patient who has already participated in a study within the last 12 months
  • Patient already enrolled in another ongoing clinical trial

For patients randomized to the Microfracture arm, the procedure will be as follows: under arthroscopy, the lesion is prepared by debriding it.

Using a specific punch, perforations are made perpendicular to the exposed bone surface.

The technical principles are as follows:

  • Perforation depth: approximately 3 to 4 mm, allowing access to the bone marrow,
  • Regular spacing between perforations: 3 to 4 mm,
  • Preservation of the integrity of the interfracture bone bridges to avoid excessive weakening of the bone endplate.

For patients randomized to the MCI arm, the procedure will be as follows: during surgery, after visualization and debridement of the lesion, cartilage tissue is harvested from a low-weight, and therefore low-stress, area. This cartilage tissue is then fragmented and mixed with PRP (Platelet-Rich Plasma), collected from the patient's blood. Platelets are unique in that they have a high concentration of universal growth factors, enabling them to heal virtually all organic tissues. Adding PRP to the fragmented cartilage tissue promotes cartilage regeneration and the incorporation of the graft into the lesion. To ensure the graft adheres to the bone tissue, it is secured biologically (with thrombin). Post-operative recovery is typical, with a gradual return to walking and other activities.

The participant participation scheme is as follows:

  • Baseline: clinical examination + MRI + self-administered questionnaires
  • Inclusion and randomization after eligibility verification
  • Day 0: surgical intervention according to randomization (MCI vs. microfractures)
  • Discharge from hospital: clinical examination + complications
  • Post-surgery visit (M3 +/- 1 month): clinical examination + self-administered questionnaires + complications + need for re-surgery
  • Post-surgery visit (M9 +/- 1 month): clinical examination + self-administered questionnaires + complications + need for re-surgery
  • Post-surgery visit (M24 +/- 1 month): clinical examination + MRI with MOCART score calculation + self-administered questionnaires + complications + need for re-surgery

To demonstrate a difference in filling rate of 30 points (90% in the MCI arm versus 60% in the Microfractures arm) with a standard deviation of 40%, a type I error rate of 5%, and a power of 80%, 28 evaluable subjects per arm are required. To account for unanalyzable data and the potential for patients lost to follow-up, we propose including a total of 80 subjects (40 per arm) in this study.

Tanulmány típusa

Beavatkozó

Beiratkozás (Becsült)

80

Fázis

  • Nem alkalmazható

Kapcsolatok és helyek

Ez a rész a vizsgálatot végzők elérhetőségeit, valamint a vizsgálat lefolytatásának helyére vonatkozó információkat tartalmazza.

Tanulmányi kapcsolat

Tanulmányi helyek

    • Grand Est
      • Essey-lès-Nancy, Grand Est, Franciaország, 54270
        • Clinique Louis Pasteur - Louis Pasteur Santé Lorraine
        • Kapcsolatba lépni:
        • Kutatásvezető:
          • Frank WEIN

Részvételi kritériumok

A kutatók olyan embereket keresnek, akik megfelelnek egy bizonyos leírásnak, az úgynevezett jogosultsági kritériumoknak. Néhány példa ezekre a kritériumokra a személy általános egészségi állapota vagy a korábbi kezelések.

Jogosultsági kritériumok

Tanulmányozható életkorok

  • Felnőtt
  • Idősebb felnőtt

Egészséges önkénteseket fogad

Nem

Leírás

Inclusion Criteria:

  • Male or female, aged over 18 years.
  • Patient who has signed an informed consent form.
  • Patient with focal cartilage lesions of the knee, classified as grade 4 on MRI according to the International Cartilage Repair Society classification (exposure of subchondral bone), regardless of size, and for which surgery is indicated.
  • Be affiliated with or a beneficiary of a social security scheme.

Exclusion Criteria:

  • Revision knee surgery
  • Body Mass Index (BMI) > 27 kg/m²
  • Joint space narrowing on standard radiographic examination
  • Refusal of consent
  • Patient unable to read, write, or understand French
  • Vulnerable patient according to Article L1121-6 of the French Public Health Code (CSP)
  • Adult patient under guardianship, curatorship, or legal protection
  • Patient unable to give Personally, their consent according to Article L.1121-8 of the French Public Health Code (CSP) or an adult protected by law
  • Pregnant or breastfeeding woman according to Article L1121-5 of the French Public Health Code (CSP)
  • Patient who has already participated in a study within the last 12 months
  • Patient already enrolled in another ongoing clinical trial

Tanulási terv

Ez a rész a vizsgálati terv részleteit tartalmazza, beleértve a vizsgálat megtervezését és a vizsgálat mérését.

Hogyan készül a tanulmány?

Tervezési részletek

  • Elsődleges cél: Kezelés
  • Kiosztás: Véletlenszerűsített
  • Beavatkozó modell: Párhuzamos hozzárendelés
  • Maszkolás: Kettős

Fegyverek és beavatkozások

Résztvevő csoport / kar
Beavatkozás / kezelés
Aktív összehasonlító: Arm 1: Microfractures

For patients randomized to the Microfracture arm, the procedure will be as follows: under arthroscopy, the lesion is prepared by debriding it.

Using a specific punch, perforations are made perpendicular to the exposed bone surface.

The technical principles are as follows:

  • Perforation depth: approximately 3 to 4 mm, allowing access to the bone marrow,
  • Regular spacing between perforations: 3 to 4 mm,
  • Preservation of the integrity of the interfracture bone bridges to avoid excessive weakening of the bone endplate.

Patients will be randomized in the study to:

  • Either the Microfracture arm
  • Or the Minced Cartilage Implantation (MCI) arm
Más nevek:
  • Management of focal cartilage lesions of the knee: Minced Cartilage Implantation (MCI)
Kísérleti: Arm 2: Minced Cartilage Implantation (MCI)
For patients randomized to the MCI arm, the procedure will be as follows: during surgery, after visualization and debridement of the lesion, cartilage tissue is harvested from a low-weight, and therefore low-stress, area. This cartilage tissue is then fragmented and mixed with PRP (Platelet-Rich Plasma), collected from the patient's blood. Platelets are unique in their high concentration of universal growth factors, and therefore have the ability to promote the healing of almost all organic tissues. This addition of PRP to the fragmented cartilage tissue will thus promote cartilage regeneration and the incorporation of the graft within the lesion. To ensure the graft adheres to the bone tissue, the entire structure is secured biologically (thrombin). Postoperative recovery is standard, with a gradual resumption of walking and activities.

Patients will be randomized in the study to:

  • Either the Microfracture arm
  • Or the Minced Cartilage Implantation (MCI) arm

Mit mér a tanulmány?

Elsődleges eredményintézkedések

Eredménymérő
Intézkedés leírása
Időkeret
Bone grafting
Időkeret: at 24 months after surgery
Bone grafting will be measured by magnetic resonance imaging at 24 months using the MOCART score (Magnetic Resonance Observation of Cartilage Repair Tissue 2.0 Knee Score), which assesses the rate and quality of grafting. The evaluator will be blinded to the randomization arm.
at 24 months after surgery

Másodlagos eredményintézkedések

Eredménymérő
Intézkedés leírása
Időkeret
Functional scores
Időkeret: Baseline, at 3 months, 9 months, 24 months after surgery

Scores fonctionnels :

- Visual Analogic Scale (VAS)

Baseline, at 3 months, 9 months, 24 months after surgery
Functional scores
Időkeret: Baseline 3 months, 9 months, 24 months after surgery

Scores fonctionnels :

- Self Knee Value (SKV)

Baseline 3 months, 9 months, 24 months after surgery
Functional scores
Időkeret: Baseline 3 months, 9 months, 24 months after surgery
Functional scores : Knee Injury and Osteoarthritis Outcome Score (KOOS score)
Baseline 3 months, 9 months, 24 months after surgery
Functional scores
Időkeret: Baseline 3 months, 9 months and 24 months after surgery
Tegner Lysholm activity score
Baseline 3 months, 9 months and 24 months after surgery
Post-operative complications
Időkeret: Immediately after surgery until max. 96 hours after surgery (corresponding to hospital discharge), 3 months, 9 months, 24 months after surgery
Post-operative complications of all causes
Immediately after surgery until max. 96 hours after surgery (corresponding to hospital discharge), 3 months, 9 months, 24 months after surgery
Re-intervention required
Időkeret: at 3, 9, and 24 months post-surgery
Re-intervention required
at 3, 9, and 24 months post-surgery

Együttműködők és nyomozók

Itt találhatja meg a tanulmányban érintett személyeket és szervezeteket.

Nyomozók

  • Kutatásvezető: Frank WEIN, Louis Pasteur Santé Lorraine

Publikációk és hasznos linkek

A vizsgálattal kapcsolatos információk beviteléért felelős személy önkéntesen bocsátja rendelkezésre ezeket a kiadványokat. Ezek bármiről szólhatnak, ami a tanulmányhoz kapcsolódik.

Általános kiadványok

Tanulmányi rekorddátumok

Ezek a dátumok nyomon követik a ClinicalTrials.gov webhelyre benyújtott vizsgálati rekordok és összefoglaló eredmények benyújtásának folyamatát. A vizsgálati feljegyzéseket és a jelentett eredményeket a Nemzeti Orvostudományi Könyvtár (NLM) felülvizsgálja, hogy megbizonyosodjon arról, hogy megfelelnek-e az adott minőség-ellenőrzési szabványoknak, mielőtt közzéteszik őket a nyilvános weboldalon.

Tanulmány főbb dátumok

Tanulmány kezdete (Becsült)

2026. július 1.

Elsődleges befejezés (Becsült)

2030. február 1.

A tanulmány befejezése (Becsült)

2030. február 1.

Tanulmányi regisztráció dátumai

Először benyújtva

2026. május 19.

Először nyújtották be, amely megfelel a minőségbiztosítási kritériumoknak

2026. június 9.

Első közzététel (Tényleges)

2026. június 11.

Tanulmányi rekordok frissítései

Utolsó frissítés közzétéve (Tényleges)

2026. június 11.

Az utolsó frissítés elküldve, amely megfelel a minőségbiztosítási kritériumoknak

2026. június 9.

Utolsó ellenőrzés

2026. június 1.

Több információ

A tanulmányhoz kapcsolódó kifejezések

További vonatkozó MeSH feltételek

Egyéb vizsgálati azonosító számok

  • 2026-A00152-49

Terv az egyéni résztvevői adatokhoz (IPD)

Tervezi megosztani az egyéni résztvevői adatokat (IPD)?

NEM

Gyógyszer- és eszközinformációk, tanulmányi dokumentumok

Egy amerikai FDA által szabályozott gyógyszerkészítményt tanulmányoz

Nem

Egy amerikai FDA által szabályozott eszközterméket tanulmányoz

Nem

Ezt az információt közvetlenül a clinicaltrials.gov webhelyről szereztük be, változtatás nélkül. Ha bármilyen kérése van vizsgálati adatainak módosítására, eltávolítására vagy frissítésére, kérjük, írjon a következő címre: register@clinicaltrials.gov. Amint a változás bevezetésre kerül a clinicaltrials.gov oldalon, ez a webhelyünkön is automatikusan frissül. .

Iratkozz fel